The medicinal properties of cannabis are being increasingly appreciated. However, a study in Lancet Psychiatry finds that people who use it every day may be at increased risk for psychotic disorder, especially if they use a high-potency form of the drug.
Humans, like most animals, are affected by sunlight or the lack of it, both physically and emotionally. But some people are affected much more than others. During the shorter, darker days of late fall and winter, especially in more northern regions, they may experience a type of clinical depression called seasonal affective disorder (SAD), also called…
Post-traumatic stress disorder (PTSD) is a serious disorder that can lead to difficulty with family, friends, and work and increase the risk of suicide, so getting effective treatment is essential. Findings from a recent study in JAMA Psychiatry are helping doctors get a better handle on which approach—medication, psychotherapy, or a combination of the two—is best.
Exercise is an important—and often overlooked—strategy for both preventing and treating depression, according to a research review in Current Sports Medicine Reports.
Many people can benefit from the companionship of an emotional support animal, reducing or even eliminating the need to take medication, such as for anxiety or depression. But what constitutes an actual need for a companion animal is debatable, and undoubtedly there is plenty of fraud.
Witnessing a loved one’s critical illness can take a mental toll on family members, sometimes leading to a condition called postintensive care syndrome-family, or PICS-F. Depression, anxiety, and PTSD are the most common symptoms.
Disappointing results from two studies that tested combinations of ingredients with purported antidepressive effects.
While the epidemic of opioid overdoses in the United States usually takes center stage in news media reports, fewer alarms have been raised about benzodiazepines--a group of sedatives used to treat anxiety and insomnia.
Half a dozen studies have found that the drug prazosin, used to treat high blood pressure and several other conditions, helps with nightmares and other symptoms in people with post-traumatic stress disorder (PTSD). So researchers were surprised when a new, larger study did not confirm this effect.
In March, the U.S. Food and Drug Administration (FDA) announced the approval of the first wholly new medication to ease severe depression since fluoxetine (Prozac) debuted in 1988. The announcement may offer some hope for a select group of people who have major depressive disorder, especially those who have suicidal thoughts, and who aren't helped by…